Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Diversity & Inclusion Drug Development
Equitable Healthcare Starts with Medical Affairs
Because they serve as the bridge between research and commercial functions of life sciences companies, medical affairs can drive equity in clinical trials by proactively engaging with a diverse set… Continue reading →

Read the article
KOL Engagement
A Case Study on Global KOL Engagement
In a recent issue of Nature that traced the origins of key opinion leaders in pharma back to a Pfizer launch in the mid-1950s, the article tracked the evolution and… Continue reading →

Read the article
KOL Engagement
Reuters Pharma and MAPS 2022 Event Wrap-Up
Events are back in person and there’s a buzz in the air. Stacey Rivkin, H1’s VP of Client Strategy & Solutions just got back from the 2022 Medical Affairs… Continue reading →

Read the article
Provider Data
Healthcare Innovation Needs Foundational Provider Data First
In the age of voice-activated smart speakers, phones and technology, very soon making a doctor’s appointment or finding a new doctor will be as simple as speaking the words. This… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Recognized as One of Forbes’ Best Startup Employers 2022
H1, which provides the largest global healthcare professional data ecosystem to enable life sciences, academic medical institutions, health systems, and payers, today announced it has been included on Forbes’… Continue reading →

Read the article
Research
H1 Acquires Faculty Opinions, Enhances Impact
When I started H1, I had one purpose in mind: to create a healthier future. With that goal at the forefront, the immediate follow-up question becomes “How?”. We do… Continue reading →

Read the article

«‹7 8 91011 12 13 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕